SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is drawing significant community attention as investors debate whether current price consolidation offers a prime entry point or signals further downside. Supporters are heavily focused on the token's role within the Base ecosystem and potential utility integrations, while discussion remains split between calls for a massive short squeeze and concerns regarding sustained volume.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly remains a central market focus as strong demand for its GLP-1 weight-loss and diabetes franchise drives consistent institutional interest and multiple target price hikes. The community is actively debating the company's competitive position in the oral drug market and its aggressive expansion strategy through recent biotech acquisitions, while monitoring the ongoing sector rotation that continues to favor large-cap biopharma leaders.

Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.

AtaiBeckley Inc.

ATAI is experiencing a surge in volatility and investor interest fueled by an acquisition offer from Eli Lilly, which has triggered widespread debate over the valuation and the future of the company's CVR-laden deal structure. While some investors are aggressively positioning for a potential bidding war or improved terms, others are expressing frustration over a perceived undervaluation of the pipeline and are scrutinizing the long-term trade-offs of the buyout.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is experiencing intense selling pressure as investors react to the company's approved reverse stock split and ongoing concerns regarding heavy dilution. Community discourse is sharply divided between those warning of a potential delisting or further price erosion and bargain hunters who believe the stock's significant Bitcoin treasury holdings offer a contrarian opportunity.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Singapore.

Seagate Technology Holdings Plc

Seagate Technology is trending as part of a broader, high-momentum rally in memory and storage stocks driven by persistent AI infrastructure demand and tight supply constraints. Community sentiment remains focused on the sector's long-term potential as a critical AI bottleneck, though traders are actively debating the sustainability of the current price surge and monitoring for potential profit-taking.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is capturing significant investor attention following positive phase 3 trial results for its thyroid eye disease treatment, which the community sees as a potential best-in-class competitor to existing blockbuster therapies. Discussion is heavily focused on the drug's improved convenience and safety profile, with many investors actively debating its massive addressable market and long-term potential as a primary M&A target.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Investors are closely monitoring Luckin Coffee for a potential rebound as the stock faces downward pressure amid broader Chinese equity volatility. The community remains focused on the company's aggressive international store expansion and the impact of the recently authorized share repurchase program on long-term value.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as investors react to a significant volume-driven rally and anticipation of upcoming earnings, with the community actively debating whether the move indicates institutional accumulation or a precursor to potential M&A activity. Long-term stakeholders are highlighting the company's strong pipeline and clinical progress as key catalysts, while traders remain hyper-focused on the significance of the stock reclaiming the key price level and the potential for a short squeeze.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

Investors are actively debating UAMY's role as a critical sole-source supplier of antimony to the U.S. military, with community sentiment split between frustration over price volatility and bullish conviction regarding future defense contracts. The ongoing conversation centers on the company's progress in domestic mining and refining capabilities, which many hope will serve as a long-term catalyst against foreign supply dependency.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors rally around the company's strategic partnership with the U.S. Army to develop rare earth separation facilities on domestic military installations, effectively positioning it as a key player for meeting future defense supply chain requirements. The community remains highly active, debating the stock's long-term potential as a 'mine-to-magnet' solution amid sector-wide volatility and the upcoming 2027 statutory ban on Chinese-origin rare earths.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OneWater Marine (ONEW) Surges 5.0%: Is This an Indication of Further Gains?

OneWater Marine (ONEW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Clarus (CLAR) Q1 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Clarus Corporation (CLAR) Matches Q1 Earnings Estimates

Clarus (CLAR) delivered earnings and revenue surprises of 0.00% and +1.10%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Clarus (NASDAQ:CLAR) Raised to Strong-Buy at Zacks Research

Zacks Research upgraded shares of Clarus from a "hold" rating to a "strong-buy" rating in a research report on Monday...

Clarus Corporation (NASDAQ:CLAR) Receives Average Recommendation of "Hold" from Brokerages

Shares of Clarus Corporation (NASDAQ:CLAR - Get Free Report) have earned a consensus rating of 'Hold' from the five ratings firms that are covering the stock, Marketbeat Ratings reports. One research...

Best Income Stocks to Buy for May 5th

VAC, CLAR and CNQ made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 5, 2026.

New Strong Buy Stocks for May 5th

WKC, VAC, CLAR, CNK and GMED have been added to the Zacks Rank #1 (Strong Buy) List on May 5, 2026.

OneWater Marine (ONEW) Reports Q2 Loss, Misses Revenue Estimates

OneWater Marine (ONEW) delivered earnings and revenue surprises of -477.78% and -8.58%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Clarus (CLAR) Projected to Post Earnings on Thursday

Clarus (NASDAQ:CLAR) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-clarus-co-stock...

Clarus Group Inc. Sells 3,185 Shares of NVIDIA Corporation $NVDA

Clarus Group Inc. reduced its position in shares of NVIDIA Corporation (NASDAQ:NVDA - Free Report) by 7.6% during the fourth quarter, according to the company in its most recent 13F filing with the...

Clarus Corp engages in the development, manufacture, and distribution of outdoor equipment and lifestyle products. The firm’s brands include Black Diamond, Rhino-Rack, MAXTRAX, and RockyMounts. It operates through Outdoor and Adventure segments. The Outdoor segment manufactures outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment sells automotive roof racks, trays, mounting systems, luggage boxes, carriers, and accessories. The company was founded in 1989 and is headquartered in Salt Lake City, UT.

Clarus Corp

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

CLARClarus Corp

Fundamentals

Latest CLAR News